Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
Repligen (RGEN) Tops Q3 EPS by 12c, Revenues Beat; Offers FY20 EPS/Revenue Guidance Above Consensus
November 5, 2020 7:47 AM ESTRepligen (NASDAQ: RGEN) reported Q3 EPS of $0.40, $0.12 better than the analyst estimate of $0.28. Revenue for the quarter came in at $94.1 million versus the consensus estimate of $86.45 million.
Reports record quarterly revenue of $94.1 million with strong margin expansionOverall revenue grew 35% year-over-year, with organic growth of 31%Raises revenue guidance to $348-$352 million and overall revenue growth to 29%-30% for full year 2020, representing 23%-24% organic growthCompletes acquisition of Non-Metallic Solutions and announces agreement to acquire bioprocess systems innovator ARTeSYN BiosolutionsTony J. Hunt, President and Chief Executive Officer said, We are... More
